Codes / HCPCS / G0434

G0434 Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter

HCPCS code

HCPCSDMEPOS

Chat with GenHealth to automate any coding or chart task.

Name of the Procedure:

Drug Screen, Other than Chromatographic; Any Number of Drug Classes, by CLIA Waived Test or Moderate Complexity Test, Per Patient Encounter (G0434)

Common Names:

  • Rapid Drug Test
  • Point-of-Care Drug Screening
  • CLIA Waived Drug Test

Technical Terms:

  • Immunoassay Screening
  • Urine Drug Screen (UDS)

Summary

A drug screening procedure designed to detect the presence of multiple drug classes in a patient's urine using a test that can be performed quickly at the point of care. It uses immunoassay techniques to provide rapid results, typically within a few minutes, and does not involve chromatographic methods.

Purpose

This procedure helps diagnose and monitor substance use, misuse, or abuse. The test aims to:

  • Identify the presence of specific drugs in the body
  • Ensure patient safety in clinical settings (e.g., during pre-op evaluation)
  • Support substance abuse treatment programs
  • Fulfill regulatory or employment-related drug testing requirements

Indications

  • Suspicion of drug misuse or abuse
  • Monitoring compliance in substance abuse treatment
  • Pre-employment or workplace drug screening
  • Post-accident or rehabilitation assessment
  • Evaluation of patients presenting with symptoms suggestive of drug intoxication or overdose

Preparation

  • No special preparation is required for the patient.
  • The patient may need to provide a urine sample in a clean container.
  • The practitioner may advise the patient to avoid certain medications or foods that could interfere with test results.

Procedure Description

  1. Sample Collection: The patient provides a urine sample.
  2. Test Administration:
    • A test strip or cassette is used to analyze the urine sample.
    • The sample is applied to the test device, which has antibodies designed to detect specific drug metabolites.
  3. Results Interpretation:
    • Results appear on the test device within a few minutes, usually in the form of lines or color changes.
    • A control indicator ensures the test is working correctly.
    • Positive or negative results are interpreted based on the appearance or absence of lines.

Tools and Equipment:

  • Test strips or cassettes, collection cups, gloves

Anesthesia or Sedation: Not applicable

Duration

The entire procedure, from sample collection to result interpretation, typically takes 10-15 minutes.

Setting

The procedure can be performed in various settings including:

  • Outpatient clinics
  • Doctor's offices
  • Rehabilitation centers
  • Workplace health units

Personnel

  • Medical Assistants
  • Nurses
  • Physicians
  • Trained Technicians

Risks and Complications

  • False Positives: Certain medications or foods could cause incorrect positive results.
  • False Negatives: Diluted urine samples or recent cessation of drug use might yield negative results despite actual use.
  • Sample Adulteration: Patients may attempt to tamper with their urine samples to alter results.

Benefits

  • Rapid, on-site results providing immediate information
  • Non-invasive and easy to perform
  • Helps in making timely clinical decisions
  • Supports patient compliance in treatment programs

Recovery

  • No recovery time needed.
  • Patients may be given further instructions based on test results, such as referrals or modifications to current treatment plans.
  • Follow-up appointments may be scheduled if necessary.

Alternatives

  • Chromatographic Tests (e.g., GC-MS, LC-MS):
    • Pros: Greater accuracy and specificity
    • Cons: Longer turnaround time, requires more sophisticated equipment and trained personnel
  • Blood or Saliva Drug Tests:
    • Pros: Different detection time windows and matrices
    • Cons: More invasive, variable detection limits

Patient Experience

  • During Procedure:
    • The patient will provide a urine sample in a private setting.
    • Minimal discomfort or inconvenience.
  • After Procedure:

    • If the test is positive, further testing may be required for confirmation.
    • Counseling or referrals may be provided depending on the results.

    Pain Management and Comfort Measures: Not typically necessary as the procedure is non-invasive and painless.

Book a walkthrough

G0434 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.